AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,275,000 | +41.7% | 70,312 | +7.1% | 0.11% | +25.6% |
| Q2 2020 | $900,000 | +4.9% | 65,659 | +9.5% | 0.09% | -18.9% |
| Q1 2020 | $858,000 | -16.3% | 59,972 | -0.9% | 0.11% | +0.9% |
| Q4 2019 | $1,025,000 | +6.4% | 60,489 | -3.3% | 0.11% | -1.8% |
| Q3 2019 | $963,000 | -35.4% | 62,557 | -1.6% | 0.11% | -32.5% |
| Q2 2019 | $1,491,000 | -15.9% | 63,591 | +1.7% | 0.17% | -19.0% |
| Q1 2019 | $1,772,000 | +12.6% | 62,557 | +19.8% | 0.20% | -6.8% |
| Q4 2018 | $1,574,000 | – | 52,217 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |